Trials / Conditions / H5N1 Virus
H5N1 Virus
3 registered clinical trials studyying H5N1 Virus.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Immunogenicity and Safety of 2 Doses of Avian Influenza A (H5N1) Vaccine Administered 3 vs. 8 Weeks Apart NCT07275060 | Canadian Immunization Research Network | Phase 4 |
| Completed | Phase I Open-Label Study of Recombinant DNA Plasmid Vaccine, VRC-AVIDNA036-00-VP, Encoding for Influenza Virus NCT00489931 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Completed | Safety Study of Avian Flu Vaccine NCT00408109 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |